Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Mostrar otras versiones (1)

Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and can be easily interfered with by various clinical conditions such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jee Hee, Kim, Jae Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801761/
https://www.ncbi.nlm.nih.gov/pubmed/33389957
http://dx.doi.org/10.4093/dmj.2020.0257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801761/
https://www.ncbi.nlm.nih.gov/pubmed/33389957
http://dx.doi.org/10.4093/dmj.2020.0257

Ejemplares similares